J P Rindone

Summary

Country: USA

Publications

  1. ncbi Late onset purple toe syndrome with warfarin successfully treated with fondaparinux
    Joseph P Rindone
    Department of Clinical Pharmacy, Northern Arizona VA Health Care System, Prescott, 86313, USA
    Am J Ther 18:e277-9. 2011
  2. ncbi Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee
    J P Rindone
    Veterans Affairs Medical Center, Prescott, AZ 86313, USA
    West J Med 172:91-4. 2000
  3. ncbi Effect of atorvastatin 15 mg/week on serum lipids in patients with hypercholesterolemia
    J P Rindone
    Veterans Affairs Medical Center, Prescott, Arizona 86313, USA
    Am J Cardiol 87:341-2, A9. 2001

Collaborators

Detail Information

Publications3

  1. ncbi Late onset purple toe syndrome with warfarin successfully treated with fondaparinux
    Joseph P Rindone
    Department of Clinical Pharmacy, Northern Arizona VA Health Care System, Prescott, 86313, USA
    Am J Ther 18:e277-9. 2011
    ..The warfarin was stopped, and fondaparinux was substituted with prompt resolution of all his symptoms. This is the first case describing late onset purple toe syndrome with warfarin with successful substitution with fondaparinux...
  2. ncbi Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee
    J P Rindone
    Veterans Affairs Medical Center, Prescott, AZ 86313, USA
    West J Med 172:91-4. 2000
    ..To determine the effectiveness of glucosamine in reducing pain from osteoarthritis of the knee...
  3. ncbi Effect of atorvastatin 15 mg/week on serum lipids in patients with hypercholesterolemia
    J P Rindone
    Veterans Affairs Medical Center, Prescott, Arizona 86313, USA
    Am J Cardiol 87:341-2, A9. 2001
    ..Atorvastatin 15 mg/week was administered to 21 patients with hypercholesterolemia for 2 months. The mean low-density lipoprotein concentration decreased by 20% after treatment...